4//SEC Filing
Luptakova Katarina 4
Accession 0001415889-24-000278
CIK 0001840233other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:15 PM ET
Size
5.5 KB
Accession
0001415889-24-000278
Insider Transaction Report
Form 4
Luptakova Katarina
CHIEF MEDICAL OFFICER
Transactions
- Award
Restricted Stock Units
2024-01-01+66,500→ 66,500 total→ Common Stock (66,500 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents the contingent right to receive one share of the issuer's common stock.
- [F2]These RSUs were granted on January 1, 2024 and will vest in four equal annual installments beginning on January 1, 2025 and continuing through January 1, 2028.
Documents
Issuer
Xilio Therapeutics, Inc.
CIK 0001840233
Entity typeother
Related Parties
1- filerCIK 0001991149
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:15 PM ET
- Size
- 5.5 KB